NEJM Interview: Dr. Walid Gellad on strategies for managing the cost of drugs receiving accelerated FDA approval. - a podcast by The New England Journal of Medicine

Dr. Walid Gellad is an associate professor of medicine and health policy and codirector of the Center for Pharmaceutical Policy and Prescribing at the University of Pittsburgh. Stephen Morrissey, the interviewer, is the Managing Editor of the Journal. W.F. Gellad and A.S. Kesselheim. Accelerated Approval and Expensive Drugs - A Challenging Combination. N Engl J Med 2017;376:2001-4.

Further episodes of 301 Moved Permanently

Further podcasts by The New England Journal of Medicine

Website of The New England Journal of Medicine